Abstract
Many cytokines alter the half-lives and stabilities of mRNAs for other cytokines (1) and enzymes that may be related to disease progression. For example, IL-1β stabilizes the mRNA for human interstitial collagenase-1 in normal fibroblasts, but not in breast cancer cells (2). Altering mRNA stability through direct control of specific RNase activity is a rapid way for cells to respond to environmental changes. Small differences in half-life can have dramatic effects on expressed products; a sixfold increase in μ heavy-chain mRNA half-life in differentiated B-cells largely accounted for a 100-fold increase in its messenger concentration compared to the undifferentiated cells (3). The high specific activity of RNases makes them ideal cellular targets for interaction with cytokines (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
*
A “back of the envelope” calculation, based on a specific activity of 5×107 interferon units/mg protein, a molecular weight of 28,000 for the dimeric protein, 106 cells/mL in the IFN assay and a 10% binding efficiency to the cell receptors, would suggest that 100–400 molecules/cell are necessary to exert an antiviral effect
References
Rai, R. M., Loffreda, S., Karp, C. L., Yang, S. Q., Lin, H. Z., and Diehl, A. M. (1997) Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 25, 889–895.
Rutter, J. L., Benbow, U., Coon, C. I., and Brinckerhoff, C. E. (1997) Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1 beta (IL-1 beta) in human fibroblasts and BC-8701 breast cancer cells. J. Cell. Biochem. 66,322–336.
Cox, A. and Emtage, J. S. (1989) A 6-fold difference in the half-life of immunoglobulin μ heavy chain mRNA in cell lines representing two stages of B-cell differentiation. Nucleic Acids Res. 17, 10,439–10,454.
Schein, C. H. (1997) From housekeeper to microsurgeon: the diagnostic and therapeutic potential of ribonucleases. Nat. Biotechnol. 15, 529–536.
Schluns, K. S., Cook, J. E., and Le, P. T. (1997) TGF-beta differentially modulates epidermal growth factor-mediated increases in leukemia-inhibitory factor, IL-6, IL-1 alpha, and IL-1 beta in human thymic epithelial cells. J. Immunol. 158, 2704–2712.
Calleja, C, Eeckhoutte, C, Larrieu, G., Dupuy, J., Pineau, T., and Galtier, P. (1997) Differential effects of interleukin-1 beta, interleukin-2, and interferon-gamma on the inducible expression of CYP 1A1 and CYP 1A2 in cultured rabbit hepatocytes. Biochem. Biophys. Res. Comm. 239, 273–278.
Zhou, X., Polgar, P., and Taylor, L. (1998) Roles for interleukin-1beta, phorbol ester and a post-transcriptional regulator in the control of bradykinin B1 receptor gene expression. Biochem. J. 330, 361–366.
Schein, C. H., Haugg, M., and Benner, S. A. (1990) Interferon-γ activates the cleavage of double stranded RNA by bovine seminal ribonuclease. FEBS Lett. 270, 229–232.
Schein, C. H. and Haugg, M. (1995) The role of the C-terminus of human interferon-γ in RNA binding and activation of the cleavage of ds-RNA by bovine seminal ribonuclease. Biochem. J. 307, 123–127.
Lengyel, P. (1993) Tumor-suppressor genes: news about the interferon connection. Proc. Natl. Acad. Sci. USA 90, 5893–5895.
Dong, B., Xu, L., Zhou, A., Hassel, B. A., Lee, X., Torrence, P. F., and Silverman, R. H. (1994) Intrinsic molecular activities of the interferon-induced 2–5A-dependent RNase. J. Biol. Chem. 269, 14,153–14,158.
Carroll, S. S., Cole, J. L., Viscount, T., Geib, J., Gehman, J., and Kuo, L. C. (1997) Activation of RNase L by 2′,5′-oligoadenylates. Kinetic characterization. J. Biol. Chem. 272, 19,193–19,198.
Bisbal, C, Martinand, C, Silhol, M., Lebleu, B., and Salehzada, T. (1995) Cloning and characterization of a RNase L inhibitor. A new component of the interferon-regulated 2–5A pathway. J. Biol. Chem. 270, 13,308–13,317.
Der, S. D., Zhou, A., Williams, B. R. G, and Silverman, R. H. (1998) Identification of genes differentially regulated by interferon α, β or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95, 623–628.
Gessani, S., DiMarzio, P., Rizza, P., Belardelli, F., and Baglioni, C. (1991) Posttranscriptional regulation of interferon mRNA levels in peritoneal macrophages. J. Virol. 65, 989–991.
Lappin, D. F., Guc, D., Hill, A., McShane, T., and Whaley, K. (1992) Effect of interferon-γ on complement gene expression in different cell types. Biochem. J. 281, 437–442.
Radzich, D. and Varesio, L. (1991) c-fos mRNA expression in macrophages is down-regulated by interferon-γ at the post-transcriptional level. Mol. Cell. Biol. 11, 2718–2722.
Kasama, T., Strieter, R. M., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., and Kunkel, S. L. (1995) Interferon gamma modulates the expression of neutrophil-derived chemokines. J. Invest. Med. 43, 58–67.
Besançon, F., Przewlocki, G., Baró, I., Hongre, A., Escande, D., and Edelman, A. (1994) Interferon-γ downregulates CFTR expression in epithelial cells. Am. J. Physiol. (Cell Physiol. 36, C1398–C1404.
Clerch, L. B., Wright, A., and Massaro, D. (1993) Endotoxin induces rat lung ribonuclease activity. FEBS Lett. 328, 250–252.
Youle, R. J., Wu, Y., Mikulski, S. M., Shogen, K., Hamilton, R. S., Newton, D., D’Alessio, G., and Gravell, M. (1994) RNase inhibition of human immunodeficiency virus infection of H9 cells. Proc. Natl. Acad. Sci. USA 91, 6012–6016.
Wu, Y., Saxena, S. K., Ardelt, W., Gadina, M., Mikulski, S. M., De Lorenzo, C, D’Alessio, G., and Youle, R. J. (1995) A study of the intracellular routing of cytotoxic ribonucleases. J. Biol. Chem. 270, 17,476–17,481.
Däubener, W., Nockemann, S., Gutsche, M., and Hadding, U. (1995) Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferonγ. Eur. J. Immunol. 25, 688–692.
Korlipara, L. V. P., Pleass, H. C. C, Taylor, R. M. R., Proud, G, Forsythe, J. L. R., and Kirby, J. A. (1994) Heparin antagonizes the induction of class II MHC molecules by interferon-γ. Transplantation 58, 1426–1429.
Schein, C. H. (1997) An enzymatic cell-free assay to detect direct inhibitors of interferon-γ. In Vitro Toxicol. 10, 275–285.
Jermann, T. M., Opitz, J. G., Stackhouse, J., and Benner, S. A. (1995) Reconstructing the evolutionary history of the artiodactyl ribonuclease superfamily. Nature 374, 57–59.
Buschle, M., Campana, D., Carding, S. R., Richard, C, Hoffbrand, A. V., and Brenner, M. K. (1993) Interferon-γ inhibits apoptotic cell death in B cell chronic lymphocyte leukemia. J. Exp. Med. 177, 213–218.
Gu, D., Wogensen, L., Calcutt, N. A., Xia, C, Zhu, S., Merlie, J. P., Fox, H. S., Lindstrom, J., Powell, H. C, and Sarvetnick, N. (1995) Myasthenia gravis-like syndrome induced by expression of interferon-γ in the neuromuscular junction. J. Exp. Med. 181, 547–557.
Koch, A. E., Kunkel, S. L., and Streiter, R. M. (1995) Cytokines in rheumatoid arthritis. J. Invest. Med. 43, 28–38.
Gutterman, J. U. (1994) Cytokine therapeutics: lessons from interferon α. Proc. Natl. Acad. Sci. USA 91, 1198–1205.
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841–848.
Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P. (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240–247.
Hemmi, S., Merlin, G, and Aguet, M. (1992) Functional characterization of a hybrid human-mouse interferon γ receptor: evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc. Natl. Acad. Sci. USA 89, 2737–2741.
Huang, S., Hendriks, W., Althage A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., and Aguet, M. (1993) Immune response in mice that lack the interferonγ receptor. Science 259, 1742–1745.
Fidler, I. J., Fogler, W. E., Kleinerman, E. S., and Saiki, I. (1985) Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-γ encapsulated in liposomes. J. Immunol. 135, 4289–4296.
Sancéau, J., Sondermeyer, P., Béranger, F., Falcoff, R., and Vaquero, C. (1987) Intracellular human γ-interferon triggers an antiviral state in transformed murine cells. Proc. Natl. Acad. Sci. USA 84, 2906–2910.
McDonald, H. S., Kushnayov, V. N., Sedmak, J. J., and Grossberg, S. E. (1986) Transport of gamma interferon into the cell nucleus may be mediated by nuclear membrane receptors. Biochem. Biophys. Res. Comm. 138, 254–260.
Deutscher, M. P. (1988) The metabolic role of RNases. TIBS 13, 136–139.
Deutscher, M. P. (1990) Introduction to an issue devoted to E. coli ribonucleases. Biochemie 72, 769.
Tsuji, H., Murai, K., Akagi, K., and Fujishima, M. (1990) Effects of recombinant leukocyte interferon on ribonuclease activities in serum in chronic hepatitis B. Clin. Chem. 36, 913–916.
Lee, F. S. and Vallee, B. L. (1993) Structure and action of mammalian ribonuclease (angiogenin) inhibitor. Prog. Nucleic Acid Res. Mol. Biol. 44, 1–30.
Shapiro, R., Weremocicz, S., Riordan, J. F., and Vallee, B. L. (1987) Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues. Proc. Natl. Acad. Sci. USA 84, 8783–8787.
Rosenberg, H. F., Tenen, D. G., and Ackerman, S. J. (1989) Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc. Natl. Acad. Sci. USA 86, 4460–4464.
Ardelt, W., Mikulski, S. M., and Shogen, K. (1991) Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. J. Biol. Chem. 266, 245–251.
Mosimann, S. C, Ardelt, W., and James M. N. G. (1994) Refined 1.7 Å X-ray crystallo-graphic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity. J. Mol. Biol. 236, 1141–1153.
Hulst, M. M., Himes G., Newbign, E., and Moormann, R. J. M. (1994). Glycoprotein E2 of classical swine fever virus; expression in insect cells and identification as a ribonuclease. Virology 200, 558–565.
Roozen, K. J., Fenwick, R. G, Jr., and Curtiss, R. (1971) Synthesis of ribonucleic acid and protein in plasmid-containing minicells of Escherichia coli K-12. J. Bacteriol. 107, 21–33.
Goff, S. A., Casson, L. P., and Goldberg, A. L. (1984) Heat shock regulatory gene htpR influences rates of protein degradation and expression of the lon gene in Escherichia coli. Proc. Natl. Acad. Sci. USA 81, 6647–6651.
Rink, H., Liersch, M., Sieber, P., and Meyer, F. (1984) A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech Hirudo medicinalis and its expression in E. coli. Nucleic Acids Res. 12, 6369–6387.
Nambiar, K. P., Stackhouse, J., Presnell, S. R., and Benner, S. A. (1987). Expression of bovine pancreatic ribonuclease A in Escherichia coli. Eur. J. Biochem. 163, 67–71.
Preuss, K.-D., Wagner, S., Freudenstein, J., and Scheit, K. H. (1990) Cloning of cDNA encoding the complete precursor for bovine seminal ribonuclease. Nucleic Acids Res. 18, 1057.
Boix, E., Nogués, M. V., Schein, C. H., Benner, S. A., and Cuchillo, C. M. (1994) Reverse transphosphorylation by ribonuclease A needs an intact p2 binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme. J. Biol. Chem. 269, 2529–2534.
Schein, C. H., Boix, E., Haugg, M., Holliger, K. P., Hemmi, S., Frank, G, and Schwalbe, H. (1992) Secretion of mammalian ribonucleases from E. coli using the signal sequence of murine spleen ribonuclease. Biochem. J. 283, 137–144.
Schein, C. H. and Noteborn, M. H. M. (1988) Production of soluble recombinant mammalian proteins in Escherichia coli is favored by lower growth temperature. Bio/Technology 6, 291–294.
Schein, C. H. (1989) Production of soluble recombinant proteins in bacteria. Bio/Technology 7, 1141–1149.
Schein, C. H. (1999) Protein expression, soluble, in The Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis and Bioseparation (Flickinger, M. C. and Drew, S. W., eds.), Wiley, New York, pp. 2156–2169.
Schein, C. H. (1990) Solubility as a function of protein structure and solvent components. Bio/Technology 8, 308–317.
Rosenberg, A. H., Lade, B. N. L., Chui, D. S., Dunn, J. J., and Studier, F. W. (1987) Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56, 125–135.
Picard, D. and Schaffner, W. (1983) Correct transcription of a cloned mouse immunoglobulin gene in vivo. Proc. Natl. Acad. Sci. USA 80, 417–421.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Schein, C.H. (2001). Producing Soluble Recombinant RNases and Assays to Measure Their Interaction with Interferon-γ In Vitro□. In: Schein, C.H. (eds) Nuclease Methods and Protocols. Methods in Molecular Biology™, vol 160. Humana Press. https://doi.org/10.1385/1-59259-233-3:113
Download citation
DOI: https://doi.org/10.1385/1-59259-233-3:113
Publisher Name: Humana Press
Print ISBN: 978-0-89603-679-6
Online ISBN: 978-1-59259-233-3
eBook Packages: Springer Protocols